Tirzepatide Failed to Protect Against Cisplatin Chemotherapy Brain Damage in Rats | Research

The takeaway

Despite anti-inflammatory promise, tirzepatide did not prevent cisplatin-induced neurotoxicity or cognitive impairment (chemobrain) in a rat model.

No neuroprotective effect
Tirzepatide failed to mitigate cisplatin-induced cognitive impairment in rats

What the researchers found

Tirzepatide did not protect against cisplatin-induced neurotoxicity or cognitive impairment in female rats.

Why it matters

The negative result is important — it tempers enthusiasm for repurposing GLP-1/GIP agonists as neuroprotective agents in the chemotherapy setting.

How the study worked

Preclinical animal study with 40 female Wistar rats in four groups (control, cisplatin, tirzepatide, cisplatin + tirzepatide) assessing neurotoxicity endpoints.

What this study cannot tell us

Animal model — rat neurotoxicity may not perfectly mirror human chemobrain; single dose/duration tested; only female rats used.

How to read the evidence

Preclinical animal study — provides mechanistic insight but negative results in rats may not definitively rule out human benefit.

When this study was published

Published 2026. Important negative result for the GLP-1 neuroprotection field.

The bigger picture

While GLP-1 RAs show neuroprotective potential in some contexts (neurodegeneration, depression), this study suggests these benefits may not extend to chemotherapy-induced brain injury.

Questions still open

Would different dosing regimens or timing of tirzepatide produce different results?
Do other GLP-1 RAs show neuroprotective effects in chemobrain models?

Common questions

What is chemobrain?

Chemobrain refers to cognitive impairment (memory problems, difficulty concentrating, mental fog) that can occur during and after chemotherapy treatment, affecting over 70% of cancer survivors.

Does this mean GLP-1 drugs can't protect the brain?

Not necessarily — GLP-1 drugs show neuroprotective potential in other contexts (like neurodegeneration), but this specific study found they didn't help with chemotherapy-induced brain damage in rats.

Read the original research

The lack of efficacy of tirzepatide in mitigating cisplatin-induced neurotoxicity and cognitive impairment in rats.

Frontiers in toxicology, 8, 1752511

View on PubMed ↗Publisher’s paper ↗

Citation

Almutairi, Hanan Mubarak; Alhowail, Ahmad Hamad. (2026). The lack of efficacy of tirzepatide in mitigating cisplatin-induced neurotoxicity and cognitive impairment in rats.. Frontiers in toxicology, 8, 1752511. https://doi.org/10.3389/ftox.2026.1752511